Perrigo | PRGO - Cost Of Sales


Perrigo reported $708.9M in Cost of Sales for its fiscal quarter ending in June of 2026.





Cost Of Sales Change Date
AbbVie USD 4.29B 73M Jun/2026
Abbott USD 5.94B 642M Jun/2026
Bayer EUR 4.54B 692M Jun/2026
Bristol-Myers Squibb USD 7.89B 4.03B Jun/2026
Coherus Biosciences USD 4.04M 324K Dec/2025
Corcept Therapeutics USD 4.06M 1.18M Jun/2026
Dr.Reddys Laboratories INR 39.22B 1.52B Jun/2026
Eli Lilly USD 3.27B 309M Jun/2026
J&J USD 8B 67M Jun/2026
Merck USD 3.14B 200M Jun/2026
Nestle CHF 23.12B 1.97B Jun/2026
Pacira USD 58.49M 7.75M Jun/2026
Perrigo USD 708.9M 65.2M Jun/2026
Pfizer USD 4.09B 498M Jun/2026
Phibro Animal Health USD 240.42M 2.58M Dec/2025
Prestige Brands USD 135.22M 5.54M Jun/2026
Reckitt Benckiser GBP 2.75B 1.34B Dec/2024
Sanofi EUR 3.02B 656M Jun/2026
Supernus Pharmaceuticals USD 59M 9.97M Jun/2026
Teva Pharmaceutical Industries USD 1.98B 30M Jun/2026
Xeris Pharmaceuticals USD 10.57M 3.08M Mar/2026
Zoetis USD 704M 32M Jun/2026